A common profile of disordered Angiogenic factor production and the exacerbation of inflammation in early preeclampsia, late preeclampsia, and intrauterine growth restriction

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Kwiatkowski, Sebastian ^a   Dołȩgowska, Barbara ^a   Kwiatkowska, Ewa ^a   Rzepka, Rafał ^a   Torbè, Andrzej ^a   Bednarek Jȩdrzejek, Magdalena ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; C REACTIVE PROTEIN; INTERLEUKIN 6; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IL6 PROTEIN, HUMAN; PGF PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PROTEIN SYNTHESIS; TROPHOBLAST; BLOOD; IMMUNOLOGY; METABOLISM; PREGNANCY; SECOND TRIMESTER PREGNANCY; YOUNG ADULT;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INTERLEUKIN-6; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; YOUNG ADULT;

EID: 84992036784     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165060     Document Type: Article

References (30)

1. Figueras F, Gratacos E. Stage-based approach to the management of fetal growth restriction. Prenat Diagn. 2014; 34: 655-659. doi: 10.1002/pd.4412 PMID: 24839087
2. Brosens IA, Robertson WB, Dixon HG. The role of spiral arteries in the pathogenesis of preeclampsia. Obset Gynecol Annu. 1972; 1: 177-191.
3. Gerretsen GG, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to preeclampsia and fetal growth retardation. Br J Obstet Gynaecol. 1981; 88: 876-881. PMID: 7272259
4. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986; 93: 1049-1059. PMID: 3790464
5. Cindrova-Davies T, Herrera EA, Niu Y, Kindom J, Giussani DA, Burton GJ. Reduced cystathionine ylyase and increased miR-21 expression are associated with increased vascular resistance in growthrestricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol. 2013; 182: 1448-1458. doi: 10.1016/j.ajpath.2013.01.001 PMID: 23410520
6. Labarrere C, Althabe O. Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol. 1985; 20: 1-11. PMID: 4029472
7. Pathak S, Lees CC, Hackett G, Jessop F, Sebire NJ. Frequency and clinical significance of placental histological lesions in an unselected population at or near term. Virchows Arch. 2011; 459: 565-572. doi: 10.1007/s00428-011-1157-z PMID: 22038509
8. Timur H, Daglar HK, Kara O, Kirbas A, Inal HA, Turkmen GG, Yilmaz Z, Elmas B, Uygur D. A study of serum Apo A-1 and Apo B-100 levels in women with preeclampsia. Pregnancy Hypertens. 2016; 6 (2):121-5 doi: 10.1016/j.preghy.2016.04.003 PMID: 27155339
9. Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factor and uterine artery Doppler findings for characterization of different subset in preeclampsia and in isolated intrauterine growth restriction. Am J Obset Gynecol. 2006; 195: 201-207.
10. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004; 95: 884-891. doi: 10.1161/01.RES.0000147365. 86159.f5 PMID: 15472115
11. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111: 649-658. doi: 10.1172/JCI17189 PMID: 12618519
12. Wallner W, Sengerberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factor in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007; 112: 51-57.
13. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2007; 9(6): 480-485. PMID: 18367011
14. Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J. Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients. Z Geburtshilfe Neonatol. 2014 Feb; 218(1): 34-41. doi: 10.1055/s-0034-1368713 PMID: 24595913
15. Alahakoon TI, Zhang W, Trudinger BJ, Lee VW. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro-and anti-angiogenic profiles. J Matern Fetal Neonatal Med. 2014 Dec; 27(18): 1854-1859. doi: 10.3109/14767058.2014.880882 PMID: 24397483
16. Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W, et al. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. J Perinat Med. 2014 Jan; 42(1): 61-68. doi: 10.1515/jpm-2013-0074 PMID: 23929878
17. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004; 279: 48487-48490. doi: 10.1074/jbc.R400025200 PMID: 15337754
18. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol. 1996; 156: 4815-4820. PMID: 8648129
19. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol. 2003; 23: 1398-1404. doi: 10.1161/01.ATV.0000081637.36475.BC PMID: 12805076
20. Guan H, Wang P, Hui R, Edin ML, Zeldin DC, Wang DW. Adeno-associated virus-mediated human Creactive protein gene delivery causes endothelial dysfunction and hypertension in rats. Clin Chem. 2009; 55: 274-284. doi: 10.1373/clinchem.2008.115857 PMID: 19056836
21. Jialal I, Verma S, Devaraj S. Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem. 2009; 55: 206-208. doi: 10.1373/clinchem.2008.119206 PMID: 19095724
22. Farzadnia M, Ayatollahi H, Hasan-Zade M, Rahimi HR. A comparative study of serum level of vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (ICAM-1) and high sensitive C-reactive protein (hs-CRP) in normal and pre-eclamptic pregnancies. Iran J Basic Med Sci. 2013 May; 16(5): 689-693. PMID: 23826490
23. Saarelainen H, Kärkkäinen H, Valtonen P, Punnonen K, Laitinen T, Heiskanen N, et al. Flow-mediated vasodilation is not attenuated in hypertensive pregnancies despite biochemical signs of inflammation. ISRN Obstet Gynecol. 2012; 2012: 709464. doi: 10.5402/2012/709464. Epub 2012 Jan 17. PMID: 22462005
24. Can M, Sancar E, Harma M, Guven B, Mungan G, Acikgoz S. Inflammatory markers in preeclamptic patients. Clin Chem Lab Med. 2011 Sep; 49(9): 1469-1472. doi: 10.1515/CCLM.2011.232 PMID: 21913791
25. Cheng PJ, Huang SY, Su SY, Hsiao CH, Peng HH, Duan T. Prognostic value of cardiovascular disease risk factors measured in the first-trimester on the severity of preeclampsia. Medicine (Baltimore). 2016 Feb; 95(5): e2653.
26. Udenze I, Amadi C, Awolola N, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015; 20: 219. doi: 10.11604/pamj.2015.20.219.5317 PMID: 26113950
27. Rahardjo B, Widjajanto E, Sujuti H, Keman K. Different levels of IL-1α, IL-6, TNF-α, NF-κB and PPAR-γ in monocyte cultures exposed by plasma preeclampsia and normotensive pregnancy. Pregnancy Hypertens. 2014 Jul; 4(3): 187-193. doi: 10.1016/j.preghy.2014.03.001 PMID: 26104604
28. Elfayomy AK, Habib FA, Almasry SM, Safwat MD, Eldomiaty MA. Serum levels of adrenomedullin and inflammatory cytokines in women with term idiopathic intrauterine growth restriction. J Obstet Gynaecol. 2013 Feb; 33(2): 135-139. doi: 10.3109/01443615.2012.721821 PMID: 23445133
29. Reimer T, Rohrmann H, Stubert J, Pecks U, Glocker MO, Richter DU, et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J Matern Fetal Neonatal Med. 2013 Feb; 26(3): 263-269. doi: 10.3109/14767058.2012.733747 PMID: 23020582
30. Ouyang YQ, Li SJ, Zhang Q, Xiang WP, Shen HL, Chen HP, et al. Plasma sFlt-1-to-PlGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women. Arch Gynecol Obstet. 2009 Jul; 280(1): 91-97. doi: 10.1007/s00404-008-0874-2 PMID: 19099313